These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12296990)
1. Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects. John BA; Brodie RR; Baldock GA; McBurney A; Chasseaud LF; Jank P; Von Nieciecki A Xenobiotica; 2002 Aug; 32(8):699-713. PubMed ID: 12296990 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects. Webber C; Roth A; Persiani S; Peard AJ; Makovec F; Kapil RP; John BA; Holding JD; D'amato M; Cybulski ZR; Chasseaud LF; Rovati LC Xenobiotica; 2003 Jun; 33(6):625-41. PubMed ID: 12851039 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. Tanaka Y; Sekiguchi M; Sawamoto T; Hata T; Esumi Y; Sugai S; Ninomiya S Eur J Drug Metab Pharmacokinet; 1994; 19(1):47-58. PubMed ID: 7957452 [TBL] [Abstract][Full Text] [Related]
4. Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. Lien EA; Anker G; Lønning PE; Ueland PM Ther Drug Monit; 1995 Jun; 17(3):259-65. PubMed ID: 7624922 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of droloxifene in the CD-1 mouse, Fischer-344 rat and cynomolgus monkey. O'Donnell JP; Khosla NB; Dalvie DK Xenobiotica; 1998 Feb; 28(2):153-66. PubMed ID: 9522440 [TBL] [Abstract][Full Text] [Related]
6. Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women. Seely EW; Brosnihan KB; Jeunemaitre X; Okamura K; Williams GH; Hollenberg NK; Herrington DM Clin Endocrinol (Oxf); 2004 Mar; 60(3):315-21. PubMed ID: 15008996 [TBL] [Abstract][Full Text] [Related]
7. First-pass metabolism and biliary recirculation of droloxifene in the female Sprague-Dawley rat. Nickerson DF; Tess DA; Toler SM Xenobiotica; 1997 Mar; 27(3):257-64. PubMed ID: 9141233 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. Grill HJ; Pollow K Am J Clin Oncol; 1991; 14 Suppl 2():S21-9. PubMed ID: 1962593 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women. Herrington DM; Pusser BE; Riley WA; Thuren TY; Brosnihan KB; Brinton EA; MacLean DB Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1606-12. PubMed ID: 10845879 [TBL] [Abstract][Full Text] [Related]
11. Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans. Zhou SF; Paxton JW; Tingle MD; Kestell P; Jameson MB; Thompson PI; Baguley BC Xenobiotica; 2001 May; 31(5):277-93. PubMed ID: 11491389 [TBL] [Abstract][Full Text] [Related]
12. Oral absorption, metabolism and excretion of 1-phenoxy-2-propanol in rats. Saghir SA; Brzak KA; Bartels MJ Xenobiotica; 2003 Oct; 33(10):1059-71. PubMed ID: 14555341 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and enantioselective pharmacokinetics of Casodex in man. McKillop D; Boyle GW; Cockshott ID; Jones DC; Phillips PJ; Yates RA Xenobiotica; 1993 Nov; 23(11):1241-53. PubMed ID: 8310708 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog. John BA; Chasseaud LF; Wood SG; Forlot P Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426 [TBL] [Abstract][Full Text] [Related]
15. Excretion of hydroxylated metabolites of tamoxifen in human bile and urine. Kisanga ER; Mellgren G; Lien EA Anticancer Res; 2005; 25(6C):4487-92. PubMed ID: 16334131 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers. Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and metabolism of 14C-carprofen in man. Ray JE; Wade DN Biopharm Drug Dispos; 1982; 3(1):29-38. PubMed ID: 7082777 [TBL] [Abstract][Full Text] [Related]
18. Sucralose metabolism and pharmacokinetics in man. Roberts A; Renwick AG; Sims J; Snodin DJ Food Chem Toxicol; 2000; 38 Suppl 2():S31-41. PubMed ID: 10882816 [TBL] [Abstract][Full Text] [Related]
19. Droloxifene, a new antiestrogen: its role in metastatic breast cancer. Rauschning W; Pritchard KI Breast Cancer Res Treat; 1994; 31(1):83-94. PubMed ID: 7981460 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects. Walles M; Wolf T; Jin Y; Ritzau M; Leuthold LA; Krauser J; Gschwind HP; Carcache D; Kittelmann M; Ocwieja M; Ufer M; Woessner R; Chakraborty A; Swart P Drug Metab Dispos; 2013 Sep; 41(9):1626-41. PubMed ID: 23775850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]